Most Recent
Arcare hit with class action over excess charges
Victorian aged care provider Arcare has been hit with a class action alleging it charged residents millions of dollars for services they did not use.
Cosette takes aim at Mayne’s pleading in damages case over failed $672M merger
US drug maker Cosette wants to strike out Mayne Pharma's causation pleading in its suit seeking damages after Cosette allegedly inducing the treasurer to reject their $672 million tie-up.
IAG class action can add damages claim not tied to disclosure breach
A judge says a shareholder class action against IAG can add a new damages claim, despite the insurer arguing it was untethered from any contravention and “clearly bad in law”.
Briefly: Alphapharm, Woolworths, GitHub latest litigation targets
The latest new suits feature billion-dollar infrastructure brawls, fresh employment claims against Telstra and Woolworths, and regulators flexing their enforcement muscle.
JustAnswer agrees to $10M penalty in ACCC subscriptions trap case
Advice platform JustAnswer has agreed to a $10 million penalty in the consumer’s watchdog’s case accusing the company of duping customers into signing up for expensive monthly subscriptions.
Construction PRO
Sev.en flags misleading conduct case over sale of Millmerran stake
Power plant investor Sev.en has filed an urgent application for access to the financials of Millmerran Power Station as it looks to sell its stake in the energy infrastructure asset, saying it may have claims of misleading conduct.
Insurers seek Deloitte reports in litigation over Greensill collapse
Insurers Marsh Limited and Insurance Australia Limited are seeking production of two reports by Deloitte commissioned by a Swiss law firm in litigation over the collapse of supply chain finance company Greensill Capital. 
IAG reaches settlement in $4B litigation over Greensill collapse
Insurance Australia Limited has settled $4 billion action brought by Germany's Greensill Bank and its administrator ahead of a six-month trial against the insurer and others over the failure of the trade financier.
Cosette appeals judge’s recusal decision in Mayne’s damages case over $672M merger
US drug maker Cosette is appealing a judge’s decision not to disqualify himself from Mayne Pharma's lawsuit seeking damages over the termination of their $672 million if he is appointed to case manage the dispute. 
Cosette on hook for $13M in jilted Mayne’s legal fees
It ditched a planned $627 million union, now US drug maker Cosette must pay more than $13 million toward Mayne Pharma's costs of the legal fallout. Whether it owes the "substantial damages" Mayne is claiming is an issue for another day.